The rapid rise of weight loss drugs is generating a host of new product lines as companies hope to land on the right side of ...
Eli Lilly (LLY) is riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound — which Wall Street estimates could net the company $13.5 billion in 2024. "It's not just a flash ...
Additionally, the thrill of artificial intelligence (AI) is propelling many companies forward much faster than ...
Eli Lilly’s weight loss drugs have helped revenue and the stock price to soar in recent times. Demand is so high that Lilly and rival Novo Nordisk have ramped up manufacturing to try to address it.
Taipei, Taiwan – Ozempic is big business in China. Last year, the Danish pharmaceutical giant Novo Nordisk doubled its sales of the diabetes drug in the country to almost $700m – 5 percent of ...
After many years of slow progress, drug companies searching for the next big treatment for Alzheimer's disease are finally starting to see the fruits of their labors. A panel of brain and ...
Federal drug regulators and experts met Monday to discuss a Eli and Lilly and Co., drug designed to sl ow the progression of Alzheimer's disease. The drug may improve treatment options for ...
EXCLUSIVETwist in case of missing teenager who left a chilling note on her pillow and vanished from her Texas home... as mom ...
The rapid rise of weight loss drugs Wegovy and Mounjaro is generating a host of new product lines as companies hope to land ...
After many years of slow progress, drug companies searching for the next big treatment for Alzheimer's disease are finally starting to see the fruits of their labors. A panel of brain and ...